Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course

Expert Rev Anti Infect Ther. 2021 Apr;19(4):413-417. doi: 10.1080/14787210.2021.1828062. Epub 2020 Oct 7.

Authors

Mudit Agarwal¹, Piyush Ranjan², Ankit Mittal², Upendra Baitha²

Affiliations

¹ All India Institute of Medical Sciences, New Delhi, India.
² Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.

PMID: 32981388
DOI: 10.1080/14787210.2021.1828062

No abstract available

Keywords: COVID-19; Hydroxychloroquine; SARS-CoV-2; pre-exposure prophylaxis.

Publication types

Editorial

MeSH terms

Antimalarials / administration & dosage
Antimalarials / adverse effects
Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use
COVID-19 / epidemiology
COVID-19 / prevention & control
COVID-19 Drug Treatment*
Clinical Trials as Topic / methods
Forecasting
Humans
Hydroxychloroquine / administration & dosage*
Hydroxychloroquine / adverse effects
Pre-Exposure Prophylaxis / methods
Pre-Exposure Prophylaxis / trends*

Substances

Antimalarials
Antiviral Agents
Hydroxychloroquine